People with serious and complex medical conditions or special medical needs are statutorily exempt from the community engagement requirement. Federal implementation guidance due by June is expected to provide further detail on how states may implement this exemption. While we are seeking a federal exemption, under the law, states are allowed to define which populations qualify for the exemption. We urge Alaska Medicaid to explicitly state that HIV is a serious and complex medical condition and that all people living with HIV (both symptomatic and asymptomatic) have special medical needs and fall under this exemption.
Letter to Michigan Senate supporting bill to ensure copay assistance counts for patients
By passing SB 914, Michigan will join 26 other states, the District of Columbia, and Puerto Rico in protecting consumers purchasing insurance on the private market. This legislation ensures that copay assistance counts toward cost-sharing obligations, preventing patients from facing insurmountable financial barriers to their medications.
Letter to Massachusetts Senate supporting HIV PrEP Access Provisions and FY27 HIV/AIDS Funding
We write to thank the Massachusetts Senate for your longstanding leadership and advocacy on behalf of the HIV community and to urge you to champion two critical HIV priorities during Senate consideration of the Fiscal Year 2027 budget: (1) the comprehensive HIV PrEP access provisions adopted by the House, and (2) robust funding for the state’s HIV/AIDS and infectious disease programs.
Letter to Louisiana Senate Health Committee Opposing Copay Maximizers
While we share your commitment to addressing the high cost of prescription drugs, we strongly oppose HB 1236, legislation that would explicitly authorize the use of copay maximizer programs in Louisiana’s health insurance market.
ACA complaint filed with Pennsylvania Insurance Commissioner on Highmark Marketplace Plans
We are writing to submit a formal complaint regarding plans offered on the Pennsylvania Marketplace by Highmark Inc. Our formulary review has found that Highmark plans offered in the 2026 plan year appear to violate federal Essential Health Benefits (EHB), discrimination, and preventive health coverage requirements in the following ways: (1) use of a copay maximizer; (2) adverse tiering; and (3) non-compliant coverage of preventive health, specifically of HIV pre-exposure prophylaxis (PrEP).